New vaccine design uses immunity against influenza to offer faster protection against emerging pathogens
Strategy developed by UC Riverside-led research team speeds up production of antibodies against COVID-19
Partnership between UCR and City of Hope aims to increase diversity in cancer research
$13.7M grant from National Cancer Institute will support several projects on breast and pancreatic cancers
Study reports discovery of new cell type in thymus
UC Riverside biomedical scientists say the cells are like M cells in the gut and airways
Could exposure to chemicals in plastics predispose you and your children to cardiovascular disease?
Exposure to environmental chemicals, including those in common plastic products, has been linked with an increased risk of cardiovascular disease, or CVD, the leading cause of death worldwide. According to the World Health Organization , 17.9 million people died from CVDs in 2019. Changcheng Zhou , a professor of biomedical...
Protein found to protect females against obesity
UC Riverside mouse study describes mechanisms underlying sex differences for obesity
UC Riverside-led study sheds light on how IBD can develop
Inflammatory bowel disease, or IBD , describes Crohn’s disease and ulcerative colitis, two chronic diseases that cause inflammation in the intestines. IBD, which affects about 3 million adults in the United States, is an autoimmune disorder — a condition in which the body’s immune system attacks healthy tissues. Its symptoms...
Health impact of chemicals in plastics is handed down two generations
UC Riverside mouse study finds paternal exposure to phthalates increases risk of metabolic diseases in progeny
Monkeypox explained
UC Riverside experts discuss disease symptoms, vaccines, and anxiety management
UCR biomedical scientist joins international SARS-CoV-2 group assembled by NIAID
SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants
Should you get a second booster shot for COVID-19?
UC Riverside’s Dr. David Lo, a vaccine expert, shares his thoughts
A potential antiviral for SARS and SARS-like coronaviruses
UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed
Scientists profile FDA-approved drugs to potentially treat hundreds of genetic disorders
New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders
Researchers develop molecular traps to target SARS-CoV-2
Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells
Scientists discover new avian immunological pathway
UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines